Clinical Trials Directory

Trials / Completed

CompletedNCT02856074

Functional Prognosis in Patients With Ischemic Stroke According to the Therapeutic Strategy Used

Prognosis After Revascularization Therapy in the Dijon Ischemic Stroke Evaluation Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
821 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The current management of ischemic stroke is based on different strategies that may be combined: intravenous thrombolysis in a stroke ICU, intravenous thrombolysis in a telemedicine procedure, endovascular thrombectomy. Given this now rich therapeutic arsenal, it seems necessary to evaluate practices in local care in the field and the impact of these on the prognosis of ischemic stroke victims. The aim of this observational study is to compare these different care practices without interfering with the choice of strategy. A blood sample will also be taken at different times to study the value of growth differentiation factors (GDF) 8, 11 and 15, and Brain-derived Neurotrophic Factor as prognostic biomarkers

Conditions

Interventions

TypeNameDescription
BIOLOGICALprise de sang
OTHERquality of life questionnaire

Timeline

Start date
2016-01-13
Primary completion
2019-06-11
Completion
2020-06-01
First posted
2016-08-04
Last updated
2021-11-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02856074. Inclusion in this directory is not an endorsement.